WIB:Philadelphia - Women’s History Month; A Celebration of the Region’s Female Pioneers in Life Science
Take advantage of Philadelphia's unique historical setting, and truly celebrate our own Female Pioneers. Honoring three women who have helped set the stage and pave the way for the foundation and tremendous growth of the local Life Science industry in the Philadelphia Metro area. The idea is a true celebration: a celebration of amazing women making history! We will have cocktails, light bites, and an introduction of the Pioneers, with an opportunity for all of us to hear their stories. The event will held at the Navy Yard, at Adaptimmune's headquarters. Adaptimmune is very committed to the empowerment of women, with well over 50% of their employees being female. The Navy Yard is a culturally rich and historically significant area, which lends itself beautifully to the historical theme of the event.
5:30 p.m. - 6:15 p.m: Networking/Arrivals
6:15 p.m - 6:20 p.m: WIB Intro
6:45 p.m - 7:45 p.m: Lively discussion with our Pioneers
7:45 p.m - 8:30 p.m Networking
Moderator: Kimberly Freeman
Kimberly Freeman is Vice President at Adapatimmune US, where she works in Commercial Strategy & Planning. Freeman has extensive oncology experience including R&D, New Product Planning, Marketing, Sales, and National Accounts. Her specialties are Oncology and National Accounts.
An innovative, experienced company builder and investor, Jane Hollingsworth founded and manages Militia Hill Ventures, an organization that creates and develops high growth, high value life sciences companies, and has successfully founded, financed, grown, managed, and taken public two biopharmaceutical companies. She has been a key senior management member of a fast growing, publicly-traded, multinational Clinical Research Organization (CRO).
Hollingsworth co-founded and was CEO of NuPathe, a biopharmaceutical company focused on innovative solutions for diseases of the central nervous system, including neurological and psychiatric disorders. NuPathe was sold to Teva Pharmaceuticals in 2014. She was also Co-founder & EVP of Auxilium Pharmaceuticals, a biopharmaceutical company dedicated to providing innovative solutions for unique diseases that improve health and quality of life, which was sold to Endo Pharmaceuticals in 2015.
Maria Maccecchini is one of Philadelphia Business Journal’s 2019 Power Women: 12 who are Having an Impact on Bioscience. She founded QR Pharma in May 2008 to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She was also partner and director of two angel groups: Robin Hood Ventures and MidAtlantic Angel Group; Founder and CEO of Symphony Pharmaceuticals/Annovis (a biotech company that sold in 2001 to Transgenomic); General Manager of Bachem Bioscience, the US subsidiary of Bachem AG, Switzerland and Head Molecular Biology Mallinckrodt. Dr. Maccecchini did one postdoc at Caltech and one at the Roche Institute of Immunology. Her PhD in biochemistry is from the Biocenter of Basel with a 2 year visiting fellowship at The Rockefeller University.
Priya Buhtani is Founder & CEO RegDesk, a venture backed by IBC, Penn Medicine and DreamIt Ventures. RegDeskTM is the developer of a cutting-edge regulatory approval software solution. Its platform delivers regulatory intelligence to medical device and pharmaceutical companies that are ready to penetrate foreign markets. Its mission is to help life sciences companies reduce their time to market, eliminate the risks associated with penetrating new markets, maximize their product revenues and market share, and increase patient access to lifesaving medical devices and therapeutics.
- Members: $15
- Non-Members: $45
* - Walk-ins will be accepted at the door until event capacity is reached.
* - Cash/Check only for non-members
Parking (pay) lots located at building and side streets
Public Transport Info
Septa Broad Street line to the Navy Yard